The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment

Transplantation Proceedings

Volumn 44, Issue 1, 2012, Pages 140-143

  Yoshimura, N ^a   Ushigome, H ^a   Matsuyama, M ^a   Nobori, S ^a   Suzuki, T ^a   Sakai, K ^a   Okajima, H ^a   Okamoto, M ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; BASILIXIMAB; CD20 ANTIBODY; CD25 ANTIBODY; CREATININE; CYCLOSPORIN; GANCICLOVIR; MIZORIBINE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; BLOOD GROUP ABO INCOMPATIBILITY; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HERPES ZOSTER; HUMAN; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; LIVING DONOR; MALE; NEUTROPENIA; PLASMAPHERESIS; PRIORITY JOURNAL;

ABO BLOOD-GROUP SYSTEM; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BLOOD GROUP INCOMPATIBILITY; CREATININE; CYTOMEGALOVIRUS INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RECOMBINANT FUSION PROTEINS; RIBONUCLEOSIDES; SPLENECTOMY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863347026     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.12.009     Document Type: Conference Paper

References (14)

1. K. Mizuno, M. Tsujino, M. Takada Studies on bredinin I. Isolation, characterization and biological properties J Antibiot (Tokyo) 27 1994 775
2. H. Ishikawa Mizoribine and mycophenolate mofetil Curr Med Chem 6 1999 575
3. T. Inou, R. Kusaba, I. Takahashi Clinical trail of Bredinin in renal transplantation Transplant Proc 13 1981 315
4. H. Amemiya, S. Suzuki, S. Niiya Synergistic effect of cyclosporine and mizoribine on survival of dog renal allografts Transplantation 46 1988 768
5. S. Hosokawa, T. Ogino, H. Ihara Triple-drug therapy with mizoribine, cyclosporine and methylprednisolone (in Japanese) Ishoku 24 1988 21
6. M. Okamoto, Y. Omori, M. Ichida An autopsy case of bacterial septic shock 12 yearsfollowing ABO-incompatible renal transplantation Clin Transplant 18 2004 44
7. N. Yoshimura, H. Okajima, H. Ushigome Current status of organ transplantation in Japan and worldwide Surg Today 40 2010 514
8. K. Takahashi, K. Saito Present status of ABO-incompatible kidney transplantation in Japan Xenotransplantation 13 2006 118
9. J. Golay, L. Zaffaroni, T. Vaccari Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis Blood 95 2000 3900
10. N. Mitsuhata, R. Fujita, S. Ito Is administration of rituximab at 375 mg/m2 without splenectomy appropriate for ABO-incompatible renal transplant? Am J Transplant 5 2005 3019
11. K. Tanabe, T. Tokumoto, N. Ishikawa Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppressant Transplant Proc 31 1999 2877
12. K. Sonda, K. Takahashi, K. Tanabe Clinical pharmacokinetic study of mizoribine in renal transplantation patients Transplant Proc 28 1996 3643
13. T. Akiyama, H. Okazaki, K. Takahashi Mizoribine in combination therapy with tacrolimus for living donor renal transplantation Transplant Proc 37 2005 843
14. J.M. Sarmiento, D.H. Dockrell, T.R. Schwab Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients Clin Transplant 14 2000 136